Canadian prostate cancer study tracks Real-World treatment choices
NCT ID NCT06874114
First seen Nov 01, 2025 · Last updated May 25, 2026 · Updated 30 times
Summary
This study collects information from medical records of 700 Canadian men with metastatic hormone-sensitive prostate cancer (mHSPC) to see how doctors combine treatments like hormone therapy, newer drugs, and chemotherapy. No new treatments are given—researchers simply observe what happens in routine care. The goal is to understand real-world treatment patterns and help improve future care decisions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC HORMONE-SENSITIVE PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pentavere
Toronto, Ontario, M6G 1A1, Canada
Conditions
Explore the condition pages connected to this study.